Q4 2028
Ends Dec 30, 2028
Revenue
$0.0B
$0.0B to $0.0B
EPS
-0.05
-0.05 to -0.05
No analyst count
EPS: No analyst count
May 2, 08:21 PM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$5.87
-2.65% today
Window Change
-13.64%
Window
Oct 8, 2025 → Jun 12, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 171 bars · Oct 8, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Turn Therapeutics Inc. (TTRX) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $5.87 and down 13.6% across the available one-year price window (Oct 8, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -76.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -76.9%, free cash flow -85.9% with operating margin 0.0% and ROIC -94.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TTRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TTRX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TTRX Max Drawdown
-70.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TTRX and SPY.
EPS Consensus
-0.05
Range -0.05 → -0.05
No analyst count
vs prior: -11.0%Revenue Outlook
$0.0B
Range $0.0B → $0.0B
No analyst count
Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from FMP.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.